Insider filing · VKTX
Sarah Kathryn Rouan
Director
profile →
Viking Therapeutics, Inc.
VKTX · Healthcare · 22 filings in 24 months
ticker →
Sarah Kathryn Rouan sold $890K of Viking Therapeutics (VKTX)
Executed Oct 25 2024, disclosed Oct 25 2024, the same day.
Value, as filed
$890K
11,000 sh × $80.89
Executed
Oct 25 2024
the trade date, as filed
Disclosed
Oct 25 2024
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
SRSarah Kathryn Rouan (Director) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Viking Therapeutics, Inc. (VKTX). The largest single filing was $890K of VKTX (11,000 sh × $80.89, as filed), executed Oct 25 2024.
The name
VKTXHealthcare · Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endo…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→